Basic Drug Info
Drug Name:Naftin
Manufacturer:Merz Pharmaceuticals
Other Info:

Pharmacokinetics:In vitro and in vivo bioavailability studies have demonstrated that naftifine penetrates the stratum corneum in sufficient concentration to inhibit the growth of dermatophytes.Following a single topical application of 1% naftifine cream to the skin of healthy subjects, systemic absorption of naftifine was approximately 6% of the applied dose.

Naftifine and/or its metabolites are excreted via the urine and feces with a half-life of approximately two to three days.

Clinical Trials:

Indications and Usage
Naftin® Cream, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
TINEA PEDIS -- Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.


Tinea corporis (disorder) --

Naftin® Cream, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.
Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

Naftin® Cream, 1% is for topical use only and not for ophthalmic use.

This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.